CNY 3.05
(-0.65%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 16.04 Billion | 1.97 Billion | 780.28 Million | 6.33 Billion | -4.84 Billion | -2.36 Billion |
Net Income | 2.6 Billion | 2.34 Billion | 3.09 Billion | 2.97 Billion | 2.84 Billion | 2.44 Billion |
Depreciation & Amortization | 416.18 Million | 404.97 Million | 414.69 Million | 311.22 Million | 303.32 Million | 319.27 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 12.67 Billion | -1.94 Billion | -3.3 Billion | 1.96 Billion | -7.8 Billion | -4.2 Billion |
Other non-cash items | -1.82 Billion | 1.16 Billion | 575.9 Million | 1.07 Billion | -184.75 Million | -602.4 Million |
Investing Cash Flow | -15.92 Billion | 8.45 Billion | -11.61 Billion | -15.39 Billion | -4.79 Billion | -11.77 Billion |
Investments in PPE | -121.89 Million | -250.16 Million | -336.47 Million | -436.53 Million | -289.31 Million | -245.15 Million |
Acquisitions | 37.11 Million | 25.49 Million | -4.99 Billion | 2.33 Million | 25.72 Million | 11.88 Million |
Investment purchases | -180.82 Billion | -56.17 Billion | -107.03 Billion | -75.61 Billion | -108.46 Billion | -101.28 Billion |
Sales/Maturities of investments | 164.98 Billion | 64.85 Billion | 95.74 Billion | 60.65 Billion | 103.93 Billion | 89.74 Billion |
Other Investing Activities | -15.8 Billion | 8.7 Billion | 5 Billion | 3.98 Billion | -4.5 Billion | 11.88 Million |
Financing Cash Flow | 740.83 Million | -11.04 Billion | 7.21 Billion | 9.44 Billion | 13.27 Billion | 13.19 Billion |
Debt repayment | -2.87 Billion | -84.78 Billion | -95.52 Billion | -89.25 Billion | -78.98 Billion | -54.03 Billion |
Dividends payments | -2.05 Billion | -2.96 Billion | -3.04 Billion | -829.73 Million | -825.15 Million | -1.71 Billion |
Common Stock Repurchased | - | - | - | - | -2.15 Billion | - |
Common Stock Issuance | - | - | - | - | 2.15 Billion | - |
Other Financing Activities | -77.56 Million | 76.69 Billion | 105.79 Billion | 101.59 Billion | 95.15 Billion | 68.93 Billion |
Accounts receivables | -14.67 Billion | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | 12.67 Billion | -1.94 Billion | -3.3 Billion | 1.96 Billion | -7.8 Billion | -3.93 Billion |
Cash at beginning of period | 13.29 Billion | 13.87 Billion | 17.5 Billion | 17.15 Billion | 13.5 Billion | 14.44 Billion |
Cash at end of period | 14.16 Billion | 13.29 Billion | 13.87 Billion | 17.5 Billion | 17.15 Billion | 13.5 Billion |
Capital Expenditure | -121.89 Million | -250.16 Million | -336.47 Million | -436.53 Million | -289.31 Million | -245.15 Million |
Effect of forex changes on cash | 4.88 Million | 43.06 Million | -13.08 Million | -34.43 Million | 858 Thousand | 16.25 Million |
Net cash flow / Change in cash | 868.01 Million | -576.54 Million | -3.62 Billion | 347.52 Million | 3.64 Billion | -934.97 Million |
Free Cash Flow | 15.92 Billion | 1.72 Billion | 443.8 Million | 5.89 Billion | -5.12 Billion | -2.6 Billion |
Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 1.17 Billion | 788.85 Million | 1.09 Billion | 2.6 Billion | -478.21 Million | 1.15 Billion |
Depreciation & Amortization | - | 98.42 Million | - | 416.18 Million | 102.25 Million | -211.67 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -1.25 Billion | 4.33 Billion | -3.07 Billion | 12.67 Billion | 380.64 Million | 720.77 Million |
Other non-cash items | -6.88 Billion | -149.64 Million | 1.1 Billion | -1.82 Billion | 1.19 Billion | 2.01 Billion |
Investing Cash Flow | 2.94 Billion | -4.2 Billion | -3.54 Billion | -15.92 Billion | 3.65 Billion | -5.8 Billion |
Investments in PPE | -36.12 Million | -17.38 Million | -17.85 Million | -121.89 Million | -26.5 Million | -20.6 Million |
Acquisitions | 22.83 Million | 53.57 Million | 8.06 Million | 37.11 Million | 22.83 Million | 10.86 Million |
Investment purchases | -51.58 Billion | -53.84 Billion | -35.64 Billion | -180.82 Billion | -45.63 Billion | -43.28 Billion |
Sales/Maturities of investments | 54.54 Billion | 51.71 Billion | 37.88 Billion | 164.98 Billion | 52.95 Billion | 37.48 Billion |
Other Investing Activities | 22.83 Million | -1.88 Billion | 2.36 Billion | -15.8 Billion | 5.36 Billion | -5.78 Billion |
Financing Cash Flow | 5.45 Billion | -1.21 Billion | 3.84 Billion | 740.83 Million | 5.75 Billion | 158.71 Million |
Debt repayment | -6.47 Billion | -1.56 Billion | -1.46 Billion | -2.87 Billion | -6.01 Billion | -24.45 Billion |
Dividends payments | -1 Billion | -657.46 Million | -692.15 Million | -2.05 Billion | -565.27 Million | -388.67 Million |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -17.37 Million | 596.11 Million | -596.11 Million | -77.56 Million | 1.05 Billion | 24.99 Billion |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | -1.25 Billion | 13.27 Billion | -6.16 Billion | 12.67 Billion | 17.98 Billion | 720.77 Million |
Cash at beginning of period | 16.71 Billion | 14.84 Billion | 14.16 Billion | 13.29 Billion | 13.52 Billion | 15.53 Billion |
Cash at end of period | 18.19 Billion | 16.71 Billion | 14.84 Billion | 14.16 Billion | 14.16 Billion | 13.52 Billion |
Capital Expenditure | -36.12 Million | -17.38 Million | -17.85 Million | -121.89 Million | -26.5 Million | -20.6 Million |
Effect of forex changes on cash | -23.52 Million | 8.88 Million | -5.13 Million | 4.88 Million | -12.17 Million | -36.83 Million |
Net cash flow / Change in cash | 1.48 Billion | 1.86 Billion | 682.63 Million | 868.01 Million | 637.67 Million | -2.01 Billion |
Free Cash Flow | -6.92 Billion | 4.85 Billion | -890.06 Million | 15.92 Billion | 973.4 Million | 3.65 Billion |
600098
1815
AMERISE
EPLAS
BRN
600721